Manhattan, United States
Precision Neuroscience is making strides in the field of Medical Devices by developing innovative brain-computer interface (BCI) technology. Founded in 2021 and headquartered in the United States, the company focuses on creating brain implants to facilitate communication and independence for individuals with neurological conditions such as paralysis, spinal cord injuries, strokes, and ALS.
The company's interdisciplinary team combines expertise in neurosurgery, artificial intelligence, machine learning, and electrical engineering to translate scientific breakthroughs into practical solutions. Since inception, Precision Neuroscience has raised over $155 million and initiated human trials with prominent hospitals. A notable investment round was the $41.00M Series B in January 2023, attracting support from investors such as B Capital Group, Draper Associates, Forepont Capital Partners, Steadview Capital, re.Mind Capital, Mubadala Capital Ventures, and Alumni Ventures.
